An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention

Nicolás Castellanos-Perillaa Department of Clinical Medicine, University of Bergen, Bergen, Norway;b Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway;c Semillero de Neurociencias y Envejecimiento, Ageing Institute, Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia;d Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]

https://orcid.org/0000-0002-8229-2611 View further author information

Miguel Germán Bordab Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway;c Semillero de Neurociencias y Envejecimiento, Ageing Institute, Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia;e Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, SwedenView further author information

Dag Aarslandb Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway;f Department of Old Age Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King’s College London, London, UKView further author information

George E. Barretog Department of Biological Sciences, University of Limerick, Limerick, IrelandView further author information

An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date